Literature DB >> 21263150

Identification of HIF2alpha as an important STAT5 target gene in human hematopoietic stem cells.

Szabolcs Fatrai1, Albertus T J Wierenga, Simon M G J Daenen, Edo Vellenga, Jan Jacob Schuringa.   

Abstract

The transcription factor signal transducer and activator of transcription 5 (STAT5) fulfills essential roles in self-renewal in mouse and human hematopoietic stem cells (HSCs), and its persistent activation contributes to leukemic transformation, although little molecular insight into the underlying mechanisms has been obtained. In the present study, we show that STAT5 can impose long-term expansion exclusively on human HSCs, not on progenitors. This was associated with an enhanced cobblestone formation under bone marrow stromal cells of STAT5-transduced HSCs. Hypoxia-induced factor 2α (HIF2α) was identified as a STAT5 target gene in HSCs, and chromatin immunoprecipitation studies revealed STAT5 binding to a site 344 base pairs upstream of the start codon of HIF2α. Lentiviral RNA interference (RNAi)-mediated down-modulation of HIF2α impaired STAT5-induced long-term expansion and HSC frequencies, whereas differentiation was not affected. Glucose uptake was elevated in STAT5-activated HSCs, and several genes associated with glucose metabolism were up-regulated by STAT5 in an HIF2α-dependent manner. Our studies indicate that pathways normally activated under hypoxia might be used by STAT5 under higher oxygen conditions to maintain and/or impose HSC self-renewal properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263150     DOI: 10.1182/blood-2010-08-303669

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Dynamic HoxB4-regulatory network during embryonic stem cell differentiation to hematopoietic cells.

Authors:  Rong Fan; Sabrina Bonde; Peng Gao; Brendan Sotomayor; Changya Chen; Tyler Mouw; Nicholas Zavazava; Kai Tan
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

2.  Gene regulation of UDP-galactose synthesis and transport: potential rate-limiting processes in initiation of milk production in humans.

Authors:  Mahmoud A Mohammad; Darryl L Hadsell; Morey W Haymond
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

3.  Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis.

Authors:  Erik R Anderson; Xiang Xue; Yatrik M Shah
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

4.  Modeling dynamic functional relationship networks and application to ex vivo human erythroid differentiation.

Authors:  Fan Zhu; Lihong Shi; Hongdong Li; Ridvan Eksi; James Douglas Engel; Yuanfang Guan
Journal:  Bioinformatics       Date:  2014-08-12       Impact factor: 6.937

5.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

6.  Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML.

Authors:  C E Forristal; A L Brown; F M Helwani; I G Winkler; B Nowlan; V Barbier; R J Powell; G A Engler; S M Diakiw; A C W Zannettino; S Martin; D Pattabiraman; R J D'Andrea; I D Lewis; J P Levesque
Journal:  Leukemia       Date:  2015-04-29       Impact factor: 11.528

7.  Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.

Authors:  Bin Zhang; Ling Li; Yinwei Ho; Min Li; Guido Marcucci; Wei Tong; Ravi Bhatia
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

8.  Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Authors:  Suhu Liu; Sarah R Walker; Erik A Nelson; Robert Cerulli; Michael Xiang; Patricia A Toniolo; Jun Qi; Richard M Stone; Martha Wadleigh; James E Bradner; David A Frank
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  MBD3 mediates epigenetic regulation on EPAS1 promoter in cancer.

Authors:  Jie Cui; Biao Duan; Xuyang Zhao; Yan Chen; Shixun Sun; Wenjie Deng; Yujie Zhang; Jun Du; Yongchang Chen; Luo Gu
Journal:  Tumour Biol       Date:  2016-07-27

10.  Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Authors:  Stéphane Prost; Francis Relouzat; Marc Spentchian; Yasmine Ouzegdouh; Joseph Saliba; Gérald Massonnet; Jean-Paul Beressi; Els Verhoeyen; Victoria Raggueneau; Benjamin Maneglier; Sylvie Castaigne; Christine Chomienne; Stany Chrétien; Philippe Rousselot; Philippe Leboulch
Journal:  Nature       Date:  2015-09-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.